Showing results (811-820 of 1,823) with videos related to
Sort By:
Pageof 183
Transplantation and Cellular Therapy|March 10, 2024
Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell TransplantationAyman Sayyed, Carol Chen, Armin Gerbitz, et al.Transplantation and Cellular Therapy|March 8, 2024
Early Chimeric Antigen Receptor T Cell Expansion Is Associated with Prolonged Progression-Free Survival for Patients with Relapsed/Refractory Multiple Myeloma Treated with Ide-Cel: A Retrospective Monocentric StudyLeo Caillot, Emmanuel Sleiman, Ingrid Lafon, et al.Transplantation and Cellular Therapy|March 8, 2024
Long-Term Clinical Outcomes and B Cell Immune Reconstitution Following Allo-HCT With Prophylactic, Post-Transplant RituximabVanessa E Kennedy, Bita Sahaf, Fang Wu, et al.Transplantation and Cellular Therapy|January 28, 2024
Clinical Impact of Cytokine Release Syndrome on Prolonged Hematotoxicity after Chimeric Antigen Receptor T Cell Therapy: KyoTox A-Score, a Novel Prediction ModelNaokazu Nakamura, Tomoyasu Jo, Yasuyuki Arai, et al.Transplantation and Cellular Therapy|January 28, 2024
Reduced Cytokine Release Syndrome and Improved Outcomes with Earlier Immunosuppressive Therapy in Haploidentical Stem Cell TransplantationJerrica Tang, Ryan R Jensen, Baylee Bryan, et al.Transplantation and Cellular Therapy|August 3, 2023
Selection of Cord Blood Unit by CD34+ Cell and GM-CFU Numbers and Allele-Level HLA Matching in Single Cord Blood TransplantationYasuo Morishima, Naoko Watanabe-Okochi, Syunro Kai, et al.Transplantation and Cellular Therapy|July 23, 2023
Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR AnalysisBrandon J Blue, Ruta Brazauskas, Karen Chen, et al.Transplantation and Cellular Therapy|March 23, 2026
GVHD prophylaxis with ATG and PTCy versus PTCy-based regimens in haploidentical stem cell transplantation: A CTTC studyAlejandro Garcia-Horton, Brittany Salter, Kristjan Paulson, et al.Transplantation and Cellular Therapy|March 27, 2026
Cognitive recovery following immune effector cell-associated neurotoxicity syndrome in the first 6 months after chimeric antigen receptor T-cell therapyChristina Kazzi, Sarah P Griffith, Katherine Y Ko, et al.Transplantation and Cellular Therapy|March 26, 2026
Adverse social determinants independently predict outcomes after allogeneic HSCTMaria Huguet, Mireia Morgades, Mercè Riquelme-Olivares, et al.Pageof 183